Prognostic Value of Severe Lymphopenia During Pelvic Concurrent Chemoradiotherapy in Cervical Cancer

Prognostic Value of Severe Lymphopenia During Pelvic Concurrent Chemoradiotherapy in Cervical Cancer

To investigate whether common terminology criteria for adverse events (CTCAE) grade 4 lymphopenia (

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anticancer research 2016-07, Vol.36 (7), p.3541-3547
Hauptverfasser: Cho, Oyeon, Chun, Mison, Chang, Suk-Joon, Oh, Young-Taek, Noh, O Kyu
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Brachytherapy
Chemoradiotherapy
Cisplatin - administration & dosage
Disease-Free Survival
Female
Humans
Lymphopenia - diagnosis
Lymphopenia - mortality
Middle Aged
Multivariate Analysis
Prognosis
Proportional Hazards Models
Retrospective Studies
Treatment Outcome
Uterine Cervical Neoplasms - diagnosis
Uterine Cervical Neoplasms - mortality
Uterine Cervical Neoplasms - therapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To investigate whether common terminology criteria for adverse events (CTCAE) grade 4 lymphopenia (
ISSN:1791-7530